Seema Nandi
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 4, 2026 | NIH | SBIR Phase II SymClot: synthetic platelet mimetic particles for point of injury care after trauma | $950K | SELSYM BIOTECH INC |
| Sep 19, 2022 | NIH | STTR Phase I SymHeal: A novel therapy for treating non-healing diabetic ulcers | $229K | SELSYM BIOTECH INC |
| Mar 10, 2022 | NIH | STTR Phase I Increasing efficiency of sdFv production in a tobacco-based system for synthetic platelet design | $259K | SELSYM BIOTECH INC with UNIVERSITY OF VIRGINIA |
| Mar 5, 2022 | NIH | STTR Phase I Increasing efficiency of sdFv production in a tobacco-based system for synthetic platelet design | $259K | SELSYM BIOTECH INC |
| May 21, 2021 | NIH | STTR Phase I Evaluation of stability and safety of platelet-like particles for treating bleeding after trauma | $255K | SELSYM BIOTECH INC |
Peer ranks
Federal funding#1,091
Awards as PI#417
Patents#273
Companies
- SELSYM BIOTECH INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.